COST Action CA18217

Concluded

November 2019 to May 2023

The global antimicrobial resistance crisis has been the driver of several international strategies on antimicrobial stewardship. Despite their good intentions, such broad strategies are only slowly being implemented into “real life”. This is particularly unfortunate for veterinary medicine, which is challenged by (i) a shortage of experts in key disciplines related to antimicrobial stewardship, (ii) few antimicrobial treatment guidelines, and (iii) inferior diagnostic tests compared to human microbiology. The aim of this Action is to optimize veterinary antimicrobial use with special emphasis on the development of antimicrobial treatment guidelines and refinement of microbiological diagnostic procedures. For this purpose, the Action will first survey the state-of-the-art in terms of microbiological diagnostic practices and veterinary treatment guidelines across Europe. Secondly, tools in the form of an extensive European strain database and a standard for making antimicrobial treatment guidelines will be created. Third, Action Participants will exploit these tools for the development and refinement of microbiological methods and European treatment guidelines. Finally, the surveys, tools, diagnostic methods, and treatment guidelines will be disseminated to national and international stakeholders. 

Funding source: H2020 COST-Action 

Working Group member of CECAV: Patrícia Poeta (WG1, WG5) 

Link: Action CA18217 – COST